Arasertaconazole - Ferrer
Alternative Names: Arasertaconazole nitrateLatest Information Update: 01 Aug 2019
At a glance
- Originator Ferrer
- Class Antifungals
- Mechanism of Action Sterol demethylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase II Vulvovaginal candidiasis
Most Recent Events
- 01 Aug 2019 Phase II development is ongoing Czech Republic, France, Hungary, Lithuania and Spain
- 15 Jan 2016 Ferrer plans a phase III trial for Vulvovaginal candidiasis in Spain (Ferrer pipeline, January 2016)
- 14 Dec 2015 Arasertaconazole is ready to enter phase III development for vulvovaginal candidiasis